Comerica Bank acquired a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,481 shares of the medical instruments supplier’s stock, valued at approximately $557,000. Comerica Bank owned 0.09% of Mesa Laboratories as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Capital Analysts LLC acquired a new position in Mesa Laboratories in the third quarter valued at $128,000. Voya Investment Management LLC acquired a new position in shares of Mesa Laboratories during the second quarter worth about $221,000. Strs Ohio increased its stake in shares of Mesa Laboratories by 5.6% during the second quarter. Strs Ohio now owns 1,900 shares of the medical instruments supplier’s stock worth $272,000 after acquiring an additional 100 shares during the period. BT Investment Management Ltd acquired a new position in shares of Mesa Laboratories during the second quarter worth about $277,000. Finally, Spark Investment Management LLC acquired a new position in shares of Mesa Laboratories during the second quarter worth about $300,000. Institutional investors own 69.79% of the company’s stock.
A number of brokerages have recently issued reports on MLAB. TheStreet upgraded shares of Mesa Laboratories from a “c+” rating to a “b” rating in a research note on Monday, November 6th. Zacks Investment Research upgraded shares of Mesa Laboratories from a “strong sell” rating to a “buy” rating and set a $167.00 price target on the stock in a research note on Tuesday, October 3rd. Finally, BidaskClub lowered shares of Mesa Laboratories from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 12th.
Mesa Laboratories, Inc. (NASDAQ MLAB) opened at $126.53 on Wednesday. Mesa Laboratories, Inc. has a one year low of $113.57 and a one year high of $169.80. The company has a current ratio of 2.86, a quick ratio of 1.97 and a debt-to-equity ratio of 0.48. The stock has a market cap of $505.65, a PE ratio of 35.39 and a beta of 0.41.
Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Monday, November 6th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.04). Mesa Laboratories had a return on equity of 14.77% and a net margin of 11.48%. The firm had revenue of $22.95 million for the quarter, compared to analyst estimates of $25.50 million. research analysts predict that Mesa Laboratories, Inc. will post 2.47 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Thursday, November 30th will be paid a dividend of $0.16 per share. The ex-dividend date is Wednesday, November 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.51%. Mesa Laboratories’s dividend payout ratio (DPR) is 23.10%.
COPYRIGHT VIOLATION WARNING: This news story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://ledgergazette.com/2017/12/06/comerica-bank-takes-position-in-mesa-laboratories-inc-mlab.html.
Mesa Laboratories Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.